Latest news


PCI Biotech to present at Bio-Europe Spring 2017

Posted on Mar 22, 2017

Oslo, Norway, March 22, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Bio-Europe Spring 2017 being held March 20-22, 2017 at the CCIB Convention Centre, Barcelona, Spain. On Wednesday, March 22, 2017 at 10:30am (CET), Mr. Gaël L’Hévéder, CBDO, will […]

PCI Biotech to present poster at 4th Immunotherapy of cancer conference

Posted on Mar 21, 2017

Oslo, Norway, March 21, 2017 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present a poster of the fimaVacc technology at the 4th Immunotherapy of cancer conference (IOTC4) – the leading international conference providing a global platform in Europe for translational research in the […]

Fourth quarter and preliminary 2016 report and presentation

Posted on Feb 28, 2017

Oslo, 28 February 2017 – Please find enclosed the financial report and presentation for fourth quarter and preliminary full year 2016. PCIB Q4 2016 Report PCIB Q4 2016 Presentation Highlights fimaCHEM Completed Phase I study in bile duct cancer, with early promising results confirmed at central expert review Oral presentation of the Phase I results […]